Last edition
News about
Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June
The experts at the summit will deliberate upon the topics like challenges and strategies for pharmaceutical business transformation, integrated packaging design for a more sustainable pharma future, new innovations in pharmaceutical packaging and brand protection, transforming pharmaceuticals with robotic solutions and AI, and how to increase
Cipla to acquire 33 per cent stake in Clean Max Auriga Power
In line with the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a captive user under electricity laws, the company has entered into agreements to acquire up to 33 per cent partnership interest in Clean Max Auriga Power LLP, the drug maker said in a regulatory filing
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Syngene International yesterday announced the extension of its long-standing multi-discipline research collaboration with Amgen Inc. The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents
Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall
Glenmark's 100% subsidiary Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, and Almirall S.A, a global biopharmaceutical company focused on skin health, announced today that they have entered into an exclusive licensing agreement for the IL-1RAP antagonist ISB 880
Lupin's Goa manufacturing plant receives EIR from US FDA
Global pharma major Lupin Limited announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (FDA) for its Goa manufacturing facility, after the inspection of the facility in September 2021
Shanghai Pharmaceuticals and Syntegon Partner to Promote Continuous Manufacturing in China
Shanghai Pharmaceuticals and Syntegon have signed an agreement to build a laboratory for continuous manufacturing technology in China. The cooperation will promote the application of this new technology, shorten development cycles of new drugs, reduce the cost of drug development, continuously improve the accessibility of new (especially orphan) drugs
Healthium Medtech has announced the launch of its latest manufacturing facility in Ahmedabad. The facility owned by Uteshiya Medicare, is located at the Rohisa Industrial Estate, and has been licenced by Healthium Medtech to exclusively manufacture its wide range of arthroscopy products marketed under the brand ?Sironix?
Parliamentary panel asks DoP to chalk out timeframe for promotion of medical devices park scheme
The Parliamentary Panel for ministry of chemicals and fertilizers has asked the Department of Pharmaceuticals (DoP) to chalk out a timeframe to complete the procedures on the scheme for promotion of medical devices parks in the country
Aurobindo and Unichem recall products in US market
Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (FDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets
KAISHA Packaging achieves record of supplying seals for two billion doses of COVID vaccines globally
KAISHA Packaging has provided over two billion doses worth of flip-top aluminium seals used for packaging COVID vaccines. The seal is used as closures for injection vials during the vaccination drive, and, is an essential part of the vaccine package ensuring tamper-proof delivery, the company notified via a statement
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy